Hjem › Interstitielle lungesygdomme › Maryland
Interstitielle lungesygdomme kliniske forsøg i Maryland
5 studier for Interstitielle lungesygdomme søger deltagere på steder i Maryland.
Byer i Maryland
Officiel studietekst (engelsk)
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 23. sep. 2026 · NCT07613099A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Baltimore
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05878717DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Maryland Medical Center, Baltimore
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 26. aug. 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Johns Hopkins University School of Medicine, Baltimore
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06195072Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Johns Hopkins Asthma and Allergy Center, Baltimore
- University of Maryland Medical Center, Baltimore
- Adventist Healthcare White Oak Medical Center, Silver Spring
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 13. jul. 2026 · NCT05943535Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.